Insulin resistance forces the pancreas to produce ever-increasing amounts of insulin to maintain blood glucose in range. Over years, the pancreatic beta-cells become exhausted by this demand and begin to fail. Once insulin secretion can no longer compensate for the resistance, blood glucose rises chronically — and the diagnosis of Type 2 Diabetes is made. This is the culmination of a process that may have been under way for a decade or more before diagnosis.

Insulin is a powerful anabolic — fat-building — hormone. When insulin is chronically elevated, it directly stimulates the liver to convert excess glucose into triglycerides through a process called de novo lipogenesis (DNL). At the same time, insulin resistance in fat tissue releases a flood of free fatty acids into the bloodstream, which the liver absorbs. The liver is simultaneously instructed by high insulin to keep making fat, and flooded with fat arriving from dysfunctional fat cells. The result is hepatic steatosis — fat accumulation in the liver. Over time this can progress to inflammation (MASH), fibrosis, cirrhosis, and even hepatocellular carcinoma.

Insulin acts on the kidneys to promote sodium and fluid retention. When insulin levels are chronically elevated, the kidneys hold onto more salt and water, raising blood volume and therefore pressure. Insulin also stimulates the sympathetic nervous system — the body's "fight or flight" response — raising heart rate and constricting blood vessels. Additionally, high insulin impairs the normal function of the endothelium (the lining of blood vessels), reducing nitric oxide production, which means vessels cannot dilate as they should. All three effects combine to raise blood pressure independently of any other cause.

Insulin resistance drives dyslipidaemia — specifically raising triglycerides and small dense LDL particles (the most damaging type) while lowering protective HDL cholesterol. High insulin promotes endothelial dysfunction, making artery walls stickier and more permeable to LDL. It also drives chronic low-grade inflammation, which is central to the development of atherosclerotic plaques. The pancreas producing excess insulin to compensate for resistance means insulin itself is reaching and acting on arterial smooth muscle cells, promoting their proliferation — thickening artery walls. The net result is accelerated cardiovascular disease.

The ovaries have insulin receptors. When insulin is chronically high, it acts directly on ovarian theca cells — the cells that produce androgens (male hormones) — stimulating excessive testosterone production. Simultaneously, high insulin suppresses the liver's production of Sex Hormone Binding Globulin (SHBG), the protein that normally binds and inactivates circulating androgens. This means not only is more testosterone being produced, but more of it is biologically active. High insulin also disrupts LH (luteinising hormone) pulsatility from the pituitary, interfering with ovulation. The resulting high androgens then worsen insulin resistance, creating a self-sustaining cycle of hormonal chaos: irregular periods, anovulation, acne, facial hair growth, and infertility.

The brain is an insulin-sensitive organ. Chronic hyperinsulinaemia in the periphery leads to impaired insulin signalling within the brain itself. The enzyme responsible for clearing amyloid-beta (the protein that accumulates in Alzheimer's plaques) — Insulin-Degrading Enzyme (IDE) — is the same enzyme that breaks down insulin. When insulin levels are persistently high, IDE is preoccupied with insulin clearance and cannot perform its secondary role of degrading amyloid. Amyloid accumulates. Additionally, brain insulin resistance leads to cerebral hypometabolism — the brain can no longer efficiently use glucose for energy — contributing to neuronal damage and cognitive decline. This connection is so well established that Alzheimer's is increasingly referred to informally as "Type 3 Diabetes".

Insulin normally suppresses the liver's production of VLDL (very low-density lipoprotein), the precursor to LDL cholesterol, and also normally suppresses fat cell lipolysis (the release of stored fatty acids). When cells become insulin-resistant but the pancreas is still pumping out high insulin, the liver paradoxically keeps producing VLDL despite high insulin (the selective insulin resistance in the liver allows glucose production and fat synthesis to continue even as glucose uptake is impaired). The result is elevated triglycerides, elevated small dense LDL particles, and low HDL — exactly the pattern associated with the highest cardiovascular risk.

Uric acid is normally excreted by the kidneys. Insulin, however, reduces the kidneys' ability to excrete uric acid — a fact well established in the medical literature. When insulin levels are chronically elevated, uric acid accumulates in the bloodstream (hyperuricaemia), eventually crystallising in joints (particularly the big toe) as gout. The high consumption of fructose — particularly from high-fructose corn syrup in processed foods — both drives insulin resistance and directly increases uric acid production, compounding the effect.

Insulin is a powerful growth factor. Cancer cells express insulin receptors and insulin-like growth factor (IGF-1) receptors. Chronically elevated insulin creates a growth-promoting environment that accelerates cell proliferation and inhibits apoptosis (programmed cell death — the body's natural mechanism for eliminating abnormal cells). Hyperinsulinaemia also promotes obesity and elevated oestrogen (through increased aromatase activity in fat tissue), further raising cancer risk. Elevated blood glucose provides the preferential fuel source for cancer cells, which rely predominantly on glucose fermentation (the Warburg Effect). Cancers of the breast, colon, endometrium, pancreas, kidney, and liver all have established associations with insulin resistance and hyperinsulinaemia.

Insulin and IGF-1 stimulate the sebaceous glands to produce sebum (skin oil) and also promote the growth of keratinocytes (skin cells that can block pores). High insulin also increases androgen levels (as described under PCOS), which further amplify sebaceous gland activity. The combination of excess sebum, blocked follicles, and androgen-driven gland enlargement creates the environment for acne. Low-glycaemic-index diets — which reduce insulin spikes — have been shown in clinical trials to significantly reduce acne severity, providing direct evidence of the insulin–acne link.

Erection is a vascular event — it requires healthy endothelial function and adequate nitric oxide production in the blood vessels supplying penile tissue. Insulin resistance impairs endothelial function, reduces nitric oxide availability, and promotes atherosclerosis in the small arteries that supply the penis. Additionally, insulin resistance frequently co-occurs with low testosterone (since high insulin suppresses sex hormone signalling), further reducing sexual function. Erectile dysfunction is now recognised as an early warning sign of cardiovascular disease and metabolic dysfunction — a vascular canary in the coal mine.

Insulin receptors are present throughout the brain, including in the prefrontal cortex and striatum — regions critical for attention, impulse control, and executive function. Brain insulin signalling modulates dopamine and norepinephrine — the very neurotransmitters implicated in ADHD. Chronically elevated insulin followed by reactive hypoglycaemia (blood sugar crashes after high-carbohydrate meals) creates dramatic swings in brain energy supply and neurotransmitter activity, directly impairing concentration and attention. Emerging research is examining the connections between dietary glycaemic load, insulin dysregulation, and ADHD symptom severity.